Anthem Biosciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Anthem Biosciences IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 8.07 and post-issue EPS of ₹ 8.04 for FY24. The pre-issue P/E ratio is 70.63x, while the post-issue P/E ratio is 70.94x against the Industry P/E ratio is 81x. The company's ROCE for FY24 is 27.64%, ROE for FY24 is 20.82% and RoNW is 20.82%. These metrics suggest that the IPO is fairly priced.

Key Performance Indicator

KPI Values
EPS Pre IPO (Rs.) ₹ 8.07
EPS Post IPO (Rs.) ₹ 8.04
P/E Pre IPO 70.63
P/E Post IPO 70.94
ROE 20.82 %
ROCE 27.64 %
P/BV 13.23
Debt/Equity 0.05
RoNW 20.82 %

Services

Equity Trading with CA Abhay

Equity Investment with CA Abhay

FNO Stocks with CA Abhay

Stock Market Masterclass

Option Trading with CA Abhay

Services

Equity Investment with CA Abhay

FNO Stocks with CA Abhay

Equity Trading with CA Abhay

Option Trading with CA Abhay

Stock Market Masterclass

onlyfans leakedonlyfan leaksonlyfans leaked videos